World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
76
Citations
20070
World Ranking
1927
National Ranking
923

Medicine

D-Index
76
Citations
20078
World Ranking
18825
National Ranking
9385

Overview

Michael D. Devous is affiliated with Avid Radiopharmaceuticals in the United States and has a substantial research profile primarily within the field of medicine. Their work extensively covers Alzheimer's disease research and treatments alongside studies on dementia and cognitive impairment.

The scientist's research spans multiple subfields including physiology, psychiatry and mental health, radiology, nuclear medicine and imaging, cognitive neuroscience, and neurology. This multidisciplinary approach supports a broad understanding of neurological disorders and brain function.

Major topics addressed in their publications include:

  • Alzheimer's disease research and treatments
  • Dementia and cognitive impairment research
  • Functional brain connectivity studies
  • Medical imaging techniques and applications
  • Neurological disease mechanisms and treatments
  • Advanced neuroimaging techniques and applications
  • S100 proteins and annexins

Frequent venues for their published work are:

  • Alzheimer's & Dementia
  • JAMA Neurology
  • Nature Medicine
  • Brain
  • Brain Communications

Notable papers authored or co-authored by Michael D. Devous include:

  • "Four distinct trajectories of tau deposition identified in Alzheimer's disease," 2021, Nature Medicine
  • "Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes," 2020, JAMA Neurology
  • "Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease," 2021, JAMA Neurology
  • "The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects," 2020, Brain
  • "Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease," 2021, JAMA Neurology

Michael D. Devous has collaborated frequently with several researchers, including:

  • Michael J. Pontecorvo
  • Michel J. Grothe
  • Adam Fleisher
  • Alexis Moscoso
  • Michael Schöll

Best Publications

  • The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

    William E. Klunk;William E. Klunk;Robert A. Koeppe;Julie C. Price;Tammie L. Benzinger;Tammie L. Benzinger

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

    Jacob W. Vogel;Yasser Iturria-Medina;Olof T. Strandberg;Ruben Smith

  • Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

    Adam J. Schwarz;Peng Yu;Bradley B. Miller;Sergey Shcherbinin

  • β-Amyloid burden in healthy aging Regional distribution and cognitive consequences

    K. M. Rodrigue;K. M. Kennedy;M. D. Devous;J. R. Rieck

  • Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

    Unknown

  • Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes

    Adam S Fleisher;Michael J Pontecorvo;Michael D Devous;Ming Lu

  • Brain Functional Localization: A Survey of Image Registration Techniques

    A. Gholipour;N. Kehtarnavaz;R. Briggs;M. Devous

  • Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

    Michael J. Pontecorvo;Michael D. Devous;Michael Navitsky;Ming Lu

  • Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology.

    Taylor W. Schmitz;R. Nathan Spreng;Michael W. Weiner;Paul Aisen

  • Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

    Alzheimer's Disease Neuroimaging Initiative

  • SPECT perfusion imaging in the diagnosis of Alzheimer’s disease: A clinical-pathologic study

    W. Jagust;R. Thisted;M.D. Devous;R. Van Heertum

  • Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects.

    Karen M. Rodrigue;Jennifer R. Rieck;Kristen M. Kennedy;Michael D. Devous

  • Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.

    Rik Ossenkoppele;Rik Ossenkoppele;Ruben Smith;Niklas Mattsson-Carlgren;Colin Groot

  • SPECT brain imaging in epilepsy: a meta-analysis

    Michael D. Devous;Ronald A. Thisted;Gillian F. Morgan;Robert F. Leroy

  • Evaluation of Neurologic Function in Gulf War Veterans: A Blinded Case-Control Study

    Robert W. Haley;Jim Hom;Peter S. Roland;Wilson W. Bryan

  • Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline A multicenter study

    P. Murali Doraiswamy;Reisa A. Sperling;R. Edward Coleman;Keith A. Johnson

  • Functional brain SPECT: the emergence of a powerful clinical method.

    B. L. Holman;M. D. Devous

  • A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.

    Michael J Pontecorvo;Michael D Devous;Ian Kennedy;Michael Navitsky

  • Subregional neuroanatomical change as a biomarker for Alzheimer's disease

    Dominic Holland;James B. Brewer;Donald J. Hagler;Christine Fennema-Notestine

  • Normal Distribution of Regional Cerebral Blood Flow Measured by Dynamic Single-Photon Emission Tomography

    M. D. Devous;E. M. Stokely;H. H. Chehabi;F. J. Bonte

  • Diffusion Tensor Tractography of Traumatic Diffuse Axonal Injury

    Jun Yi Wang;Khamid Bakhadirov;Michael D. Devous;Hervé Abdi

Frequent Co-Authors

Michael J. Pontecorvo
Michael J. Pontecorvo Eli Lilly (United States)
Denise C. Park
Denise C. Park The University of Texas at Dallas
Ramon Diaz-Arrastia
Ramon Diaz-Arrastia University of Pennsylvania
Kristen M. Kennedy
Kristen M. Kennedy The University of Texas at Dallas
Karen M. Rodrigue
Karen M. Rodrigue The University of Texas at Dallas
Adam S. Fleisher
Adam S. Fleisher Avid Radiopharmaceuticals
Mark A. Mintun
Mark A. Mintun University of Pennsylvania
Rik Ossenkoppele
Rik Ossenkoppele Lund University
William J. Jagust
William J. Jagust University of California, Berkeley

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Michael D. Devous

Trending Scientists